Checkpoint Therapeutics, Inc.
NASDAQ:CKPT
3.21 (USD) • At close January 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||
Current Assets: | |||||||||
Cash & Cash Equivalents
| 4.928 | 12.068 | 54.735 | 40.772 | 26.077 | 21.995 | 19.225 | 35.086 | 50.418 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 4.928 | 12.068 | 54.735 | 40.772 | 26.077 | 21.995 | 19.225 | 35.086 | 50.418 |
Net Receivables
| 0 | 0.073 | 0.017 | 0.02 | 0.026 | 1.532 | 0.331 | 0.821 | 0.065 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0.45 | 1.149 | 0.976 | 1.804 | 0.863 | 1.372 | 1.857 | 0.071 | 0.171 |
Total Current Assets
| 5.378 | 13.29 | 55.728 | 42.596 | 26.966 | 24.899 | 21.413 | 35.978 | 50.654 |
Non-Current Assets: | |||||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Assets
| 5.378 | 13.29 | 55.728 | 42.596 | 26.966 | 24.899 | 21.413 | 35.978 | 50.654 |
Liabilities & Equity: | |||||||||
Current Liabilities: | |||||||||
Account Payables
| 6.57 | 11.535 | 16.139 | 3.438 | 3.079 | 9.75 | 3.645 | 2.473 | 0.917 |
Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 11.855 | 21.238 | 9.843 | 3.779 | 5.04 | 3.343 | 2.727 | 1.2 | 0.873 |
Total Current Liabilities
| 18.425 | 32.773 | 25.982 | 7.217 | 8.119 | 13.093 | 6.372 | 3.673 | 1.79 |
Non-Current Liabilities: | |||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.468 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 0 | 20.297 | 0 | 0 | 0 | 0 | 0 | 0 | 2.468 |
Total Liabilities
| 18.425 | 32.773 | 25.982 | 7.217 | 8.119 | 13.093 | 6.372 | 3.673 | 4.258 |
Equity: | |||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.003 | 0.001 | 0.009 | 0.007 | 0.006 | 0.004 | 0.003 | 0.003 | 0.002 |
Retained Earnings
| -314.333 | -262.486 | -199.862 | -143.192 | -120.111 | -95.397 | -59.03 | -36.353 | -13.892 |
Accumulated Other Comprehensive Income/Loss
| 0 | 1.885 | 6.598 | 4.617 | 2.51 | 1.748 | 2.296 | 3.919 | 3.024 |
Other Total Stockholders Equity
| 301.283 | 243.002 | 216.411 | 173.947 | 136.442 | 105.451 | 71.772 | 64.736 | 57.262 |
Total Shareholders Equity
| -13.047 | -19.483 | 29.746 | 35.379 | 18.847 | 11.806 | 15.041 | 32.305 | 46.396 |
Total Equity
| -13.047 | -19.483 | 29.746 | 35.379 | 18.847 | 11.806 | 15.041 | 32.305 | 46.396 |
Total Liabilities & Shareholders Equity
| 5.378 | 13.29 | 55.728 | 42.596 | 26.966 | 24.899 | 21.413 | 35.978 | 50.654 |